Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy

Clinical trial NCT02460094 · COMPLETED

Trial details

NCT number: NCT02460094
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy

Start date: 2015-10-02
Primary completion: 2016-10-19
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.